Cargando…
The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer
The standard diagnostics procedure for non-small-cell lung cancer (NSCLC) requires a pathological evaluation of tissue samples obtained by surgery or biopsy, which are considered invasive sampling procedures. Due to this fact, re-sampling of the primary tumor at the moment of progression is limited...
Autores principales: | Bożyk, Aleksandra, Nicoś, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604747/ https://www.ncbi.nlm.nih.gov/pubmed/36295075 http://dx.doi.org/10.3390/life12101640 |
Ejemplares similares
-
Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
por: Pesta, Martin, et al.
Publicado: (2022) -
Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients
por: Nicoś, Marcin, et al.
Publicado: (2020) -
Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
por: Tomasik, Bartłomiej, et al.
Publicado: (2023) -
Liquid Biopsy in Non-Small Cell Lung Cancer
por: Molina-Vila, Miguel A., et al.
Publicado: (2016) -
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
por: Chang, Sunhee, et al.
Publicado: (2020)